Gastric Adenocarcinoma: Review and Considerations for Future Directions
暂无分享,去创建一个
John R. Mackey | Carol Cass | J. Mackey | C. Cass | D. Bigam | A. Joy | B. Dicken | S. Hamilton | Bryan J. Dicken | David L. Bigam | Anil A. Joy | Stewart M. Hamilton
[1] H. Höfler,et al. Gastric adenocarcinoma: pathomorphology and molecular pathology , 2001, Journal of Cancer Research and Clinical Oncology.
[2] I. Arribas,et al. Prognostic Value of Carcinoembryonic Antigen, CA 19-9 and CA 72-4 in Gastric Carcinoma , 2001, Tumor Biology.
[3] Alter Mj,et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. , 1991, BMJ.
[4] D. Klimstra,et al. Biologic Predictors of Survival in Node-Negative Gastric Cancer , 2003, Annals of surgery.
[5] M. Heslin,et al. Clinicopathological Characteristics of Gastric Carcinoma in Young and Elderly Patients: A Comparative Study , 2000, Annals of Surgical Oncology.
[6] Jin‐Pok Kim. Current status of surgical treatment of gastric cancer , 2002, Journal of surgical oncology.
[7] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[8] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[9] S. Seeber,et al. CHEMOTHERAPY OF GASTRIC CANCER. , 1964, Acta - Unio Internationalis Contra Cancrum.
[10] R. Semelka,et al. MRI in staging of gastric cancer , 2002, Abdominal Imaging.
[11] R. Gore. Gastric cancer. Clinical and pathologic features. , 1997, Radiologic clinics of North America.
[12] P. Fayers,et al. Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial , 1999, British Journal of Cancer.
[13] P. Cheverton,et al. Prospective randomized trial of combined oncological therapy for gastric carcinoma , 1979, Cancer.
[14] J. Yee,et al. Diagnosis and staging of gastric cancer. , 1996, Seminars in oncology.
[15] Y. Maehara,et al. Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. , 1995, Surgery.
[16] Josep M Ramon,et al. Dietary factors and gastric cancer risk. A case‐control study in Spain , 1993, Cancer.
[17] C. la Vecchia,et al. Family history and the risk of stomach and colorectal cancer , 1992, Cancer.
[18] M. Brennan,et al. Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer , 1998, Journal of Gastrointestinal Surgery.
[19] T. Sano,et al. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? , 2001, Critical reviews in oncology/hematology.
[20] Hiroki Kuniyasu,et al. Molecular diagnosis of gastric cancer: present and future , 2001, Gastric Cancer.
[21] K. Mimori,et al. Prognostic score of gastric cancer determined by cDNA microarray. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[22] S. Y. Lee,et al. Comparing MR imaging and CT in the staging of gastric carcinoma. , 2000, AJR. American journal of roentgenology.
[23] M. Braga,et al. Surgical treatment of gastric adenocarcinoma: impact on survival and quality of life. A prospective ten year study. , 1996, Hepato-gastroenterology.
[24] J. Macdonald,et al. Adjuvant treatment of gastric cancer , 1995, World Journal of Surgery.
[25] S. Msika,et al. Prognostic factors after curative resection for gastric cancer. A population-based study. , 2000, European journal of cancer.
[26] L. Franzén,et al. Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma , 2000, The British journal of surgery.
[27] A. Boussioutas,et al. Towards a molecular approach to gastric cancer management , 2001, Internal medicine journal.
[28] A. Sgadari,et al. Surgery: Independent Prognostic Factor in Curable and Far Advanced Gastric Cancer , 2000, World Journal of Surgery.
[29] S. Andreola,et al. Adequacy of Margins of Resection in Gastrectomy for Cancer , 1982, Annals of surgery.
[30] C. Li,et al. Analyzing high‐density oligonucleotide gene expression array data , 2001, Journal of cellular biochemistry.
[31] D. Kelsen. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] N. Iizuka,et al. MECHANISMS OF DISEASE Mechanisms of disease , 2022 .
[33] C. Earle,et al. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. , 1999, European journal of cancer.
[34] T. Saito,et al. Significant prognostic factors in patients with early gastric cancer. , 2000, International surgery.
[35] Rui Li,et al. Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines , 2002, Oncogene.
[36] K. Kinoshita,et al. Neoadjuvant chemotherapy for high-grade advanced gastric cancer , 1993, World Journal of Surgery.
[37] H. Putter,et al. Value of palliative resection in gastric cancer , 2002, The British journal of surgery.
[38] L. Oñate-Ocaña,et al. Survival benefit of D2 lymphadenectomy in patients with gastric adenocarcinoma , 2000, Annals of Surgical Oncology.
[39] T. Ichikura,et al. Minimum Number of Lymph Nodes that Should Be Examined for the International Union Against Cancer/American Joint Committee on Cancer TNM Classification of Gastric Carcinoma , 2003, World Journal of Surgery.
[40] H. Kuwano,et al. Total gastrectomy with distal pancreatectomy and splenectomy for advanced gastric cancer. , 2001, The Journal of surgical research.
[41] J. Voltas,et al. [Treatment of gastric cancer]. , 1982, Revista de medicina de la Universidad de Navarra.
[42] A. Rotondo,et al. Role of computerized tomography in the staging of gastrointestinal neoplasms. , 2001, Seminars in surgical oncology.
[43] Aller,et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2002, The New England journal of medicine.
[44] G. Heberer,et al. Results of gastric resection for carcinoma of the stomach: The European experience , 1988, World Journal of Surgery.
[45] E. León-Rodríguez,et al. Adenocarcinoma of the Stomach: Univariate and Multivariate Analysis of Factors Associated With Survival , 2002, American journal of clinical oncology.
[46] Tsuneo Sasaki,et al. [Gastrointestinal cancer]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.
[47] H. Hoefler,et al. The use of molecular biology in diagnosis and prognosis of gastric cancer. , 2000, Surgical oncology.
[48] Y. Kodera,et al. Extended lymph node dissection in gastric carcinoma: where do we stand after the Dutch and British randomized trials? , 2002, Journal of the American College of Surgeons.
[49] M. Tyers,et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. , 2002, Cancer research.
[50] Min Wu,et al. Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array. , 2002, World journal of gastroenterology.
[51] T. Golub,et al. DNA microarrays in clinical oncology. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] C. Caldas,et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. , 2001, The New England journal of medicine.
[53] R. Miceli,et al. Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[54] A. Ziogas,et al. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates , 2000, Cancer.
[55] M. Huguier,et al. [Extended lymph-node dissection for gastric cancer]. , 1999, Chirurgie; memoires de l'Academie de chirurgie.
[56] E Marubini,et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. , 1999, Annals of surgery.
[57] D. Shibata,et al. Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays , 2002, Oncogene.
[58] A. Hölscher,et al. Staging of gastric cancer: correlation of lymph node size and metastatic infiltration. , 1999, AJR. American journal of roentgenology.
[59] C. Earle,et al. Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline. , 2002, Canadian journal of surgery. Journal canadien de chirurgie.
[60] S. Pyrhönen,et al. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. , 1995, British Journal of Cancer.
[61] D. Cunningham,et al. Current options in the management of gastrointestinal cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[62] G. Berx,et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[63] S. Kitano,et al. Most Important Lymph Node Information in Gastric Cancer: Multivariate Prognostic Study , 2000, Annals of Surgical Oncology.
[64] S. Choi,et al. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer , 2002, Annals of Surgical Oncology.
[65] A. Hagiwara,et al. Outcome of prophylactic radical lymphadenectomy with gastrectomy in patients with early gastric carcinoma without lymph node metastasis , 2000, Cancer.
[66] L. Rabeneck,et al. Gastric ulcers at endoscopy: brush, biopsy, or both? , 1997, The American journal of gastroenterology.
[67] Keiichi Maruyama,et al. Progress in gastric cancer surgery in Japan and its limits of radicality , 1987, World Journal of Surgery.
[68] E. J. Neves,et al. Differentially expressed genes in gastric tumors identified by cDNA array. , 2003, Cancer letters.
[69] A. Petroianu,et al. Modified therapy with 5‐fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer , 1993, Cancer.
[70] F. d'angelo,et al. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection? , 2000, Hepato-gastroenterology.
[71] A. Sinha,et al. Gene expression profile analysis by DNA microarrays: promise and pitfalls. , 2001, JAMA.
[72] T. Yao,et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy , 1992, Cancer.
[73] J. Byles,et al. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis , 1999, American Journal of Gastroenterology.
[74] Y. Kodera,et al. Effects of Dietary, Drinking, and Smoking Habits on the Prognosis of Gastric Cancer , 2000, Nutrition and cancer.
[75] H. Aburatani,et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. , 2001, Cancer research.
[76] A. Hagiwara,et al. Long-term benefit of extended lymphadenectomy with gastrectomy in distally located early gastric carcinoma. , 2000, American journal of surgery.
[77] P. Stern,et al. The clinical significance of p53 accumulation in gastric carcinoma , 1996, Cancer.
[78] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[79] B. Choi,et al. MRI in staging advanced gastric cancer: is it useful compared with spiral CT? , 2000, Journal of computer assisted tomography.
[80] Y. Maehara,et al. Clinicopathological features of long-term survivors of scirrhous gastric cancer. , 2000, Hepato-gastroenterology.
[81] D. Klimstra,et al. Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?: An Analysis of 1,038 Patients , 2000, Annals of surgery.
[82] D. Driscoll,et al. Outcome of Patients With Proximal Gastric Cancer Depends on Extent of Resection and Number of Resected Lymph Nodes , 2000, Annals of Surgical Oncology.
[83] B. Glimelius,et al. A systematic overview of chemotherapy effects in gastric cancer. , 2001, Acta oncologica.
[84] L. Simon,et al. Cancer of the stomach. , 1951, Connecticut state medical journal.
[85] P. Schlag,et al. Quality of life and functional results following different types of resection for gastric carcinoma. , 1990, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[86] F. Bozzetti,et al. Principles of surgical radicality in the treatment of gastric cancer. , 2001, Surgical oncology clinics of North America.
[87] M. Brennan,et al. Total gastrectomy is not necessary for proximal gastric cancer. , 1998, Surgery.
[88] Daan Brandenbarg. The National. , 1892 .
[89] Shuichi Tsutsumi,et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. , 2002, Cancer research.
[90] C. Herfarth,et al. Imaging diagnosis for staging of gastric cancer. , 1999, Seminars in surgical oncology.
[91] T. Kim,et al. Perigastric lymph node status can be a simple prognostic parameter in patients with gastric cancer. , 2000, Hepato-gastroenterology.
[92] T. Koga,et al. Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. , 2002, Surgery.
[93] V. Schumpelick,et al. Endoscopic ultrasonography in the preoperative staging of gastric cancer , 2000, Surgical Endoscopy.
[94] M H Skolnick,et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. , 1994, Journal of the National Cancer Institute.
[95] Woo Ho Kim,et al. Identification of genes differentially expressed between gastric cancers and normal gastric mucosa with cDNA microarrays. , 2002, Cancer letters.
[96] H. Espejo,et al. [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.
[97] S. Hundahl,et al. The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy , 2000, Cancer.
[98] J. Chmiel,et al. Cancer of the stomach. A patient care study by the American College of Surgeons. , 1993, Annals of surgery.
[99] G. Thompson,et al. Adenocarcinoma of the stomach: are we making progress? , 1993, The Lancet.
[100] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[101] F. Roviello,et al. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: A longitudinal multicenter study , 2002, Annals of Surgical Oncology.
[102] G. Friedman,et al. Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.
[103] J FusterObregón,et al. Treatment of gastric cancer , 1999 .
[104] P. Hermanek,et al. Classification of regional lymph node metastasis from gastric carcinoma , 1998, Cancer.
[105] H. Allgayer,et al. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[106] S. Barni,et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[107] H. Keizer,et al. Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG). , 1999, European journal of cancer.
[108] M. Aizcorbe,et al. Impact of surgical procedure for gastric cancer on quality of life , 2003, The British journal of surgery.
[109] C. V. D. van de Velde,et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[110] M. Ogawa,et al. Involvement of three or more lymph nodes predicts poor prognosis in submucosal gastric carcinoma , 2001, Gastric Cancer.
[111] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[112] K. White,et al. Clinical epidemiology. , 1983, International journal of epidemiology.
[113] L. David,et al. Clinicopathologic Profiles and Prognosis of Gastric Carcinomas from the Cardia, Fundus/Body and Antrum , 2001, Digestive Surgery.
[114] T. Hickish,et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[115] S. Weeden,et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of MRC randomized surgical trial , 2001 .
[116] D. Roukos. Extended (D2) Lymph Node Dissection for Gastric Cancer: Do Patients Benefit? , 2000, Annals of Surgical Oncology.
[117] L. Gianni,et al. Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[118] M. Stolte,et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists , 1997, The Lancet.
[119] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[120] B. Glimelius,et al. A systematic overview of chemotherapy effects in gastric cancer. , 2001, Acta oncologica.
[121] J. Siewert,et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. , 1998, Annals of surgery.
[122] Cynthia Ludwig,et al. Gastrointestinal tract , 2005, The American Journal of Digestive Diseases.
[123] J. O'fallon,et al. Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[124] J. Byles,et al. Original ContributionsAssociation of Helicobacter pylori infection with gastric carcinoma: a meta-analysis , 1999 .
[125] E. Van Cutsem,et al. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[126] U. Haglund,et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[127] W. Carroll,et al. GENE EXPRESSION PROFILING , 2001 .
[128] H. Frierson,et al. Expression profiling of gastric adenocarcinoma using cDNA array , 2001, International journal of cancer.
[129] T. Saito,et al. Significant prognostic factors in patients with node-negative gastric cancer. , 1999, International surgery.
[130] W J Macdonald,et al. GASTRIC CARCINOMA. , 1912, Canadian Medical Association journal.
[131] Yusuke Nakamura,et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. , 2002, Cancer research.
[132] A. Kakita,et al. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status. , 2000, Anticancer research.
[133] E. Winzeler,et al. Genomics, gene expression and DNA arrays , 2000, Nature.
[134] Y. Kodera,et al. The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. , 1998, Journal of the American College of Surgeons.
[135] G. Schwartz. Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlations. , 1996, Seminars in oncology.
[136] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.
[137] C. Moskaluk,et al. Inactivation of the E-Cadherin Gene in Sporadic Diffuse-Type Gastric Cancer , 2001, Modern Pathology.
[138] Li Wang,et al. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials. , 2002, World journal of gastroenterology.
[139] J. Raoul,et al. A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination. , 2001, European journal of gastroenterology & hepatology.
[140] G. Lawrence,et al. Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancer , 2002, The British journal of surgery.